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ABSTRACT
Objective: This study was to evaluate the combination of siddha drug with allopathy medicine or only siddha drug, which is most beneficial for the 
patient to manage Madhumegam (diabetes Type-II). Comparison of two groups of diabetic patients taking siddha medicine alone and combined with 
allopathy medicine.
Methods: A pilot study was done on the management of Madhumegam patients in National Institute of Siddha (NIS) as a retrospective study. Data 
collection for assessment had been done by retrieving from the individuals’ outpatients department (OPD) records and using questionnaire method, 
at the time of OPD treatment at NIS. Data for 105 Madhumegam patients were collected and taken up for the study.
Results: The mean±standard deviation (SD) of blood sugar at fasting before and after treatment was 150±50 and 122±35, respectively, for siddha 
alone group, whereas for siddha and allopathy group, these were 146±47 and 144±47, respectively. The statistical analysis reveals that the reduction 
of blood sugar for (siddha only) Group I at fasting was statistically significant (p<0.0001) and Group II (siddha and allopathy) it was not statistically 
significant (p=0.73). The mean±SD of blood sugar at postprandial before and after treatment was 247±77 and 178±64, respectively, for siddha alone 
group, whereas for siddha and allopathy group, these were 237±85 and 229±80, respectively. The statistical analysis reveals that the reduction of 
blood sugar for (siddha only) Group I at postprandial was statistically significant (p<0.0001) and Group II (siddha and allopathy) it was not statistically 
significant (p=0.55).
Conclusion: The siddha medicine alone treated group (Group I) shows significant reduction of blood sugar both at fasting and postprandial. The 
siddha and allopathy treated group (Group II) has not shown a significant reduction.
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INTRODUCTION
Madhumegam [1] (Diabetes mellitus [DM] Type-II) is a metabolic disease 
characterized by polyuria, polyphagia, and polydipsia. It is a syndrome 
of disordered carbohydrate, protein, and lipid metabolism caused 
by insufficient insulin with the dysfunction of insulin target cells [2]. 
Over 45 million people in India have diabetes. Study finds over 42 lakhs 
in Tamil Nadu having diabetes, and another 30 lakhs are showing sure 
signs of contracting it. One in 10 people in Tamil Nadu is diabetic. Among 
developing countries, India will become the capital of diabetes. Out of 
360 million of diabetic patients in the world, it has been predicted that 
about 79.4 million people in India will suffer from diabetes in 2030 [3-7].
In the survey of diabetes in Chennai, with the age of 30 and above, 
50,000 out of 3 lakh people are affected by diabetes, 60,000 affected by 
hypertension, and 40,000 are affected by DM with hypertension [8,9].
In 1980, the WHO urged the researchers to examine whether 
traditional medicines produced any beneficial clinical result. In the last 
10-20 years, scientific investigations, in fact, confirmed the efficacy and 
safety of many of the traditional medicine preparations [10].
This is an innovative and scientific research study to make the people 
realize and understand that taking of siddha medicines for diabetic 
treatment along with allopathic medicines is not advisable because the 
siddha medicines will not work very effectively as they do when taken 
separately.
BACKGROUND OF THE STUDY
The National Institute of Siddha (NIS) is an autonomous research 
institute in siddha system under the Department of AYUSH, Government 
of India. NIS is having the facility for the Outpatients under outpatient 
department [OPD] and under inpatient department accordingly.
Every day, thousands of patients are getting benefited for their illness. 
Among them, the patients suffering with Madhumegam (diabetes) are 
more common. Many of them are taking medicines for a long period. 
Some of them are taking only siddha medicines and some of them are 
taking siddha medicines combined with allopathic medicines. They 
take siddha medicine before or after food as per the prescription of the 
physicians. They take Nilavembu Kudineer along with the Madhumega 
capsules, Keelanelli tablet, and Tripala tablet [11,12]. It is a need to rule 
out which of the above criteria is the most beneficial one for the patient 
to manage Madhumegam (diabetes). Hence, we have planned to do a 
pilot study on the management of Madhumegam patients in NIS as a 
retrospective study.
METHOD OF PILOT STUDY
The study has been conducted by retrospective analysis method.
Data collection for the assessment has been done by retrieving from the 
individuals’ OPD records and using questionnaire method, at the time of 
OPD treatment at the NIS. Assessment form has been prepared with the 
guidance of the Head of the Department, Gunapadam Department, NIS.
Inclusive criteria
• Patients taking regular treatment at OP Gunapadam Department
• Patients having treatment for not less than 3 months
• Patients having their lab investigations at least twice in their 
treatment period
• Patients willing to take part in the assessment program.
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• Comparison of two groups of diabetic (Madhumegam) patients-taking 
siddha medicine only and the patients taking siddha medicines along 
with the allopathy medicines
• Comparison of diabetic (Madhumegam) patients having food habits 
of vegetarian and non-vegetarian diets
• Comparison of medicines taken before the food and after the food.
• Ef icacy of Madhumega capsule alone and along with Nilavembu 
Kudineer
• Comparison of blood sugar level, hemoglobin (Hb), body weight, 
hemoglobin A1c (HbA1c), and cholesterol before taking the 
treatment as per the latest report of assessment.
RESEARCH DESIGN AND DATA COLLECTION
Retrospective analysis using questionnaire method; a total of 105 
Madumegam outpatients in Gunapadam Department, NIS, were 
assessed by the investigator.
Following information’s are collected from the questionnaires.
Food habits, occupation, walking exercise, yoga practice, food 
regulations, allopathic medicine, diabetic complications, and hereditary 
implications.
The following information’s are collected from the patients’ individuals’ 
records.
Blood sugar level (fasting and postprandial), Hb, lipid profile, HbA1c, 
urine sugar (fasting, postprandial, and albumin), body weight, details of 
medicine, periodic lab investigations, and treatment period.
Study period
29th July, 2011, to 28th August, 2011 (1 month).
Data analysis
Data for 105 diabetic (Madhumegam) patients were collected and taken 
up for the study.
All collected data were computerized and analyzed using descriptive 
analyzing method and statistical significance of t-test and paired t-test.
Patients have been divided into two groups (Group I and Group II) for 
the study purpose.
Group I refers to the patients who take siddha medicines only.
Group II refers to the patients who take siddha medicines along with 
allopathy medicines.
Group I consists of 42 out of 105 patients and Group II consists of 63 
out of 105 patients.
RESULTS AND DISCUSSIONS
Following are the important observations from the pilot study of the 
management of diabetes (Madhumegam).
In NIS, 40% of diabetic (Madhumegam) patients belong to Group I 
(i.e., taking siddha medicine only) and 60% belong to Group II 
(i.e., taking both siddha and allopathy medicines). This indicates that 
the users of both siddha and allopathy medicines are higher than the 
users of siddha medicines alone (Fig. 1).
The Madhumegam patients utilizing siddha medicines, belonging to 
the age group of 50 and above (71%) are higher than the age group of 
below 50 (29%) (Fig. 2).
54% of Madumegam patients are due to heredity (Fig. 3).
73% of people taking non-vegetarian food are affected with MM, and it 
is higher than the people taking vegetarian food (27%) (Fig. 4).
89% of MM patients are undergoing periodic lab investigations once 
in 3 months.
52% of Madumegam patients are taking siddha medicine before food 
and, 48% are taking after food (Fig. 5).













Fig. 1: Siddha and combined group
Fig. 2: Age
Fig. 3: Heredity
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Most of the MM patients (78%) are taking MMC capsule along with 
Nilavembu Kudineer (Fig. 6).
Very minimum people (11%) are taking MMC capsule only.
Among MM patients, 59% are also affected with hypertension.
22% of the patients taking siddha only have got hypertension and 
78% of the patients taking both siddha and allopathy have got 
hypertension (Fig. 7).
The mean±standard deviation (SD) of blood sugar at fasting before and 
after treatment was 150±50 and 122±35, respectively, for siddha alone 
group, whereas for siddha and allopathy group, these were 146±47 and 
144±47, respectively. The statistical analysis reveals that the reduction 
of blood sugar for (siddha only) Group I at fasting was statistically 
significant (p<0.0001) and Group II (siddha and allopathy) it was not 
statistically significant (p=0.73) (Table 1).
The mean±SD of blood sugar at postprandial before and after treatment 
was 247±77 and 178±64, respectively, for siddha alone group, whereas 
for siddha and allopathy group, these were 237±85 and 229±80, 
respectively. The statistical analysis reveals that the reduction of 
blood sugar for (siddha only) Group I at postprandial was statistically 
significant (p<0.0001) and Group II (siddha and allopathy) it was not 
statistically significant (p=0.55) (Table 2).
The mean±SD of Hb before and after treatment were 11±1 and 12±1 
respectively. The statistical analysis reveals that the increase of Hb was 
statistically significant (p<0.0068).
The blood sugar level of the Group I with non-vegetarian food habit is 
better controlled than the patients with vegetarian food habits.
Among MM patients, 78% are practicing walking regularly. Among 
them, male patients are 92% and it is higher than the female 
patients (67%) (Fig. 8).





















6 26 15 21
111-150 21 7 27 15
151-200 9 8 12 10
201-300 5 1 8 16
301 and above 1 0 1 1





















2 12 7 5
141-200 12 20 21 20
201-250 11 6 12 11
251-300 9 2 9 10
301-400 6 2 11 17
401< 2 - 3 -
Fig. 4: Food habits
Fig. 5: Siddha medicine intake
Fig. 6: Name of siddha medicines
Fig. 7: Complications of diabetes
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The monitoring of MM patients’ body weight, HbA1c, lipid profile is 
very poor (i.e., 6%) of NIS OPDs.
Only 5%of MM patients are doing Yoga exercise regularly.
Most of the patients taking Nilavembu Kudineer feel better.
The stability of sugar level is seen in siddha group, but a marked 
deviation is in the combined group.
CONCLUSION
The siddha medicine alone treated group (Group I) shows significant 
reduction of blood sugar both at fasting and postprandial.
The siddha and allopathy treated group (Group II) has not shown 
a significant reduction. This is perhaps due to Group I patients were 
diagnosed as new Madhumegam when they were reported for other 
illness in NIS. However, the Group II patients were already diagnosed 
and taking treatment in allopathy for a long period. Thus, taking of 
siddha treatment (Nilavembu Kudineer, MMC capsule, Keelanelli and 
Tripala tablet) at the initial stage helps in controlling the Madhumagam.
Moreover, proper and new monitoring strategies to be adopted with 
some more effective research studies to control the blood sugar level of 
the MM patients who take both siddha and allopathy medicines. A new 
therapeutic method with sastric and or newly formulated drugs may be 
tried at NIS for improvement of MM Group II.
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